Abstract:A series of compounds that target reactive transition-metal chelates to somatic angiotensin converting enzyme (sACE-1) have been synthesized. Half-maximal inhibitory concentrations (IC(50)) and rate constants for both inactivation and cleavage of full-length sACE-1 have been determined and evaluated in terms of metal chelate size, charge, reduction potential, coordination unsaturation, and coreactant selectivity. Ethylenediaminetetraacetic acid (EDTA), nitrilotriacetic acid (NTA), 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), and tripeptide GGH were linked to the lysine side chain of lisinopril by 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide hydrochloride/N-hydroxysuccinimide coupling. The resulting amide-linked chelate-lisinopril (EDTA-lisinopril, NTA-lisinopril, DOTA-lisinopril, and GGH-lisinopril) conjugates were used to form coordination complexes with iron, cobalt, nickel, and copper, such that lisinopril could mediate localization of the reactive metal chelates to sACE-1. ACE activity was assayed by monitoring cleavage of the fluorogenic substrate Mca-RPPGFSAFK(Dnp)-OH, a derivative of bradykinin, following preincubation with metal chelate-lisinopril compounds. Concentration-dependent inhibition of sACE-1 by metal chelate-lisinopril complexes revealed IC(50) values ranging from 44 to 4500 nM for Ni-NTA-lisinopril and Ni-DOTA-lisinopril, respectively, versus 1.9 nM for lisinopril. Stronger inhibition was correlated with smaller size and lower negative charge of the attached metal chelates. Time-dependent inactivation of sACE-1 by metal chelate-lisinopril complexes revealed a remarkable range of catalytic activities, with second-order rate constants as high as 150,000 M(-1) min(-1) (Cu-GGH-lisinopril), while catalyst-mediated cleavage of sACE-1 typically occurred at much lower rates, indicating that inactivation arose primarily from side chain modification. Optimal inactivation of sACE-1 was observed when the reduction potential for the metal center was poised near 1000 mV, reflecting the difficulty of protein oxidation. This class of metal chelate-lisinopril complexes possesses a range of high-affinity binding to ACE, introduces the advantage of irreversible catalytic turnover, and marks an important step toward the development of multiple-turnover drugs for selective inactivation of sACE-1.

Catalytic Mechanism of Angiotensin-Converting Enzyme and Effects of the Chloride Ion

QM/MM Investigation of the Catalytic Mechanism of Angiotensin-Converting Enzyme

Rediscovering ACE: Novel Insights into the Many Roles of the Angiotensin-Converting Enzyme

Inhibitor and substrate binding by angiotensin-converting enzyme: quantum mechanical/molecular mechanical molecular dynamics studies.

Insight into the interactive residues between two domains of human somatic Angiotensin-converting enzyme and Angiotensin II by MM-PBSA calculation and steered molecular dynamics simulation

Domain-selective ligand-binding modes and atomic level pharmacophore refinement in angiotensin I converting enzyme (ACE) inhibitors

Inhibitory Mechanism of a Substrate-Type Angiotensin I-converting Enzyme Inhibitory Peptide

Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective

[Nitric Oxide/heme Oxygenase-1 Mediates the Antioxidant Effect of ACEI in Rat Aortic Rings].

35Mhz Quartz Crystal Microbalance and Surface Plasmon Resonance Studies on the Binding of Angiotensin Converting Enzyme with Lisinopril

Exploration of Interaction Between Angiotensin I-converting Enzyme (ACE) and the Inhibitory Peptide from Wakame (undaria Pinnatifida)

Inhibition Mechanism and Model of an Angiotensin I-converting Enzyme (Ace)-Inhibitory Hexapeptide from Yeast (saccharomyces Cerevisiae).

Antihypertensive Effects, Molecular Docking Study, and Isothermal Titration Calorimetry Assay of Angiotensin I-Converting Enzyme Inhibitory Peptides from Chlorella Vulgaris.

Metal ion modulation of cystinyl aminopeptidase

Microwave-Assisted Solid-Phase Synthesis, Biological Evaluation and Molecular Docking of Angiotensin I-Converting Enzyme Inhibitors

Thermodynamics and kinetics of an enzyme-catalyzed reaction determined by isothermal titration calorimetry

Studies on the Interaction Between Angiotensin-Converting Enzyme (ACE) and ACE Inhibitory Peptide from Saurida Elongata.

Angiotensin-converting enzyme: a well-known stranger. Part I

Targeted catalytic inactivation of angiotensin converting enzyme by lisinopril-coupled transition-metal chelates.

Construction and Application of Membrane-Bound Angiotensin-I Converting Enzyme System: A New Approach for the Evaluation of Angiotensin-I Converting Enzyme Inhibitory Peptides.

Theoretical Insight into the Catalytic Mechanism of Enoyl-CoA Hydratase